Eli Lilly and Company and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino people affected by diabetes through enhanced research, education, and care.
“The tremendous burden of diabetes and cardiovascular disease bears a disproportionate weight on Latino families in the United States,” said David Kerr, M.D., FRCPE, director of Innovation and Research for the William Sansum Diabetes Center. “This collaboration with Lilly will allow us to gain a better understanding of how we can help these families.”
Dr. Kerr added that Latino people comprise 43% of the total population in Santa Barbara County, and rates of cardio-metabolic disease are persistently higher than in the rest of the population due to a combination of factors beyond biological risk, including economics, culture, and education.
For Lilly, the collaboration will provide valuable insights into patients’ unmet needs and aid in the development of interventions that could improve health outcomes for Latino people.
“This is a great opportunity for us to further understand the significant impact of diabetes for Latino families,” said Dara Schuster, M.D., senior director of U.S. Medical Affairs for Lilly Diabetes. “Through this collaboration, we will learn where the gaps are so we can develop meaningful solutions for the unmet needs.”
SOURCE: Eli Lilly and Company